Serum Zinc-α2-Glycoprotein Levels in Patients with or without Coronary Artery Disease in Chinese North Population

Figure 1

Serum ZAG levels in CAD, NCAD patients and controls. Serum ZAG levels in CAD, NCAD patients and controls of all subjects (a), males (b), and females (c), respectively. Serum ZAG levels of males and females in CAD (d), NCAD (e), and control (f) groups, respectively. CAD: coronary artery disease; NCAD: noncoronary artery disease; ZAG: zinc-α2-glycoprotein. All values are expressed as mean ± SD.

(a)

(b)

(c)

(d)

(e)

(f)